Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.49M Buy
103,378
+10,005
+11% +$262K 0.08% 162
2026
Q1
$2.62M Buy
93,373
+483
+0.5% +$12.9K 0.18% 121
2025
Q4
$2.31M Sell
92,890
-276
-0.3% -$6.96K 0.18% 141
2025
Q3
$2.37M Buy
+93,166
New +$2.3M 0.2% 140

Other funds holding PFE

Tema ETFs's PFE Position: Q2 2026 in Review

Tema ETFs increased its Pfizer (PFE) stake by 11% in Q2 2026, buying an estimated $262K and bringing the position to 103,378 shares worth $2.49M. The position accounts for 0.08% of the portfolio, ranked #162.

Tema ETFs first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.62M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Tema ETFs held 103,378 shares of Pfizer worth $2.49M as of Q2 2026.
  • Tema ETFs bought 10,005 Pfizer shares in Q2 2026, an estimated $262K.
  • Pfizer made up 0.08% of Tema ETFs's portfolio in Q2 2026, its #162 holding.
  • Tema ETFs first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • Tema ETFs's Pfizer position peaked at $2.62M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.